Log in

Natus Medical Stock Price, News & Analysis (NASDAQ:NTUS)

$30.79
+0.14 (+0.46 %)
(As of 10/16/2019 03:27 AM ET)
Today's Range
$30.71
Now: $30.79
$31.38
50-Day Range
$27.21
MA: $30.16
$32.16
52-Week Range
$22.25
Now: $30.79
$35.73
Volume163,700 shs
Average Volume261,157 shs
Market Capitalization$1.05 billion
P/E Ratio21.68
Dividend YieldN/A
Beta0.73
Natus Medical Incorporated provides neurology, newborn care, and hearing and balance assessment healthcare products and services worldwide. It offers products and services used for the screening, diagnosis, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction and neurosurgical treatments, epilepsy, sleep disorders, neuromuscular diseases, and balance and mobility disorders. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing screening products; diagnostic hearing assessment products to screen for/or diagnose hearing loss, or to identify abnormalities affecting the peripheral and central auditory nervous systems; balance and mobility systems to diagnose and assist in treating balance disorders; and thermoregulation products to control the incubators and warmers. Additionally, it offers jaundice management products; brain injury products; NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation and sound rooms to hearing and balance care professionals. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Pleasanton, California.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NTUS
CUSIPN/A
CIKN/A
Phone925-223-6700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$530.89 million
Cash Flow$2.87 per share
Book Value$11.80 per share

Profitability

Net Income$-22,930,000.00

Miscellaneous

Employees1,729
Market Cap$1.05 billion
Next Earnings Date10/24/2019 (Confirmed)
OptionableOptionable

Receive NTUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NTUS and its competitors with MarketBeat's FREE daily newsletter.


Natus Medical (NASDAQ:NTUS) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "NTUS."

How were Natus Medical's earnings last quarter?

Natus Medical Incorporated (NASDAQ:NTUS) announced its quarterly earnings results on Thursday, July, 25th. The company reported $0.34 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.30 by $0.04. The company had revenue of $125.54 million for the quarter, compared to analyst estimates of $122.85 million. Natus Medical had a negative net margin of 7.38% and a positive return on equity of 10.73%. View Natus Medical's Earnings History.

When is Natus Medical's next earnings date?

Natus Medical is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for Natus Medical.

How can I listen to Natus Medical's earnings call?

Natus Medical will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Has Natus Medical been receiving favorable news coverage?

News headlines about NTUS stock have been trending very negative this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Natus Medical earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Natus Medical.

Are investors shorting Natus Medical?

Natus Medical saw a decrease in short interest during the month of September. As of September 30th, there was short interest totalling 1,100,000 shares, a decrease of 6.0% from the August 30th total of 1,170,000 shares. Based on an average daily volume of 186,400 shares, the short-interest ratio is presently 5.9 days. Currently, 3.3% of the shares of the stock are sold short. View Natus Medical's Current Options Chain.

Who are some of Natus Medical's key competitors?

What other stocks do shareholders of Natus Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Natus Medical investors own include HealthStream (HSTM) and Alphatec (ATEC).

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:
  • Mr. Jonathan A. Kennedy CPA, Pres, CEO & Director (Age 48)
  • Mr. Benjamin Drew Davies, Exec. VP & CFO (Age 53)
  • Mr. Austin F. Noll III, Exec. VP & Chief Commercial Officer (Age 52)
  • Mr. Seán Langan, VP Global Operations
  • Mr. Ivan Pandiyan, VP of Global R&D

How do I buy shares of Natus Medical?

Shares of NTUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Natus Medical's stock price today?

One share of NTUS stock can currently be purchased for approximately $30.79.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $1.05 billion and generates $530.89 million in revenue each year. The company earns $-22,930,000.00 in net income (profit) each year or $1.42 on an earnings per share basis. Natus Medical employs 1,729 workers across the globe.View Additional Information About Natus Medical.

What is Natus Medical's official website?

The official website for Natus Medical is http://www.natus.com/.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The company can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (NASDAQ NTUS)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  7 (Thanks for Voting!)
Underperform Votes:  12 (Thanks for Voting!)
Total Votes:  19
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe NTUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NTUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: Fundamental Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel